Literature DB >> 14664321

Screening and prevention of alcohol and drug use disorders in women.

Dace S Svikis1, Kathryn Reid-Quiñones.   

Abstract

Today a variety of treatments are available for women with SUDs. They range from psychosocial interventions such as motivational enhancement therapy, cognitive-behavioral therapy, and 12-step recovery to pharmacotherapies such as buprenorphine, methadone, and naltrexone. Although the general public remains skeptical of SUD treatment, national studies consistently find it to be both clinically and economically efficacious. In Oregon, for example, researchers found that every dollar invested in drug treatment saved taxpayers dollars 5.60. By the time a woman walks through the door of a drug treatment program, however, her disorder is likely to be firmly engrained. The medical practitioner's office provides an ideal setting for screening and early identification of high-risk alcohol and other drug use and abuse. A variety of reliable and valid self-report measures are available. Sadly, however, the majority of health providers still do not routinely screen patients for alcohol or drug problems. The consequences can be severe, particularly for women. Although efforts have focused on practitioner education and strategies to address practical barriers to implementation (eg, time, resources), much less attention has focused on the pessimistic views of practitioners about SUDs and treatment efficacy. New strategies are needed to enhance practitioner feelings of self-efficacy about their ability to identify and intervene early in the progression from alcohol use to abuse to dependence.

Entities:  

Mesh:

Year:  2003        PMID: 14664321     DOI: 10.1016/s0889-8545(03)00082-2

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  4 in total

1.  Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers.

Authors:  Hendrée E Jones; Krisanna Deppen; Mark L Hudak; Lisa Leffert; Carol McClelland; Leyla Sahin; Jacquelyn Starer; Mishka Terplan; John M Thorp; James Walsh; Andreea A Creanga
Journal:  Am J Obstet Gynecol       Date:  2013-10-10       Impact factor: 8.661

2.  Gender differences in provider's use of a standardized screening tool for prenatal substance use.

Authors:  Carrie Oser; Elizabeth Biebel; Melissa Harris; Elisa Klein; Carl Leukefeld
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

3.  Protective Effects of Pregnancy on Risk of Alcohol Use Disorder.

Authors:  Alexis C Edwards; Henrik Ohlsson; Dace S Svikis; Jan Sundquist; Kristina Sundquist; Kenneth S Kendler
Journal:  Am J Psychiatry       Date:  2018-11-29       Impact factor: 18.112

4.  Prevalence and Social Acceptability of Cannabis, Tobacco, and Alcohol Use in Adult Women.

Authors:  Patricia Coughenour; Jaclyn S Sadicario; Nicole Karjane; Anna Beth Parlier-Ahmad; Lisa Phipps; Dace S Svikis
Journal:  Womens Health Rep (New Rochelle)       Date:  2021-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.